Egetis Therapeutics’ Shares Offering

Vinge advised Egetis Therapeutics on the deal. Egetis Therapeutics AB (publ), listed on Nasdaq Stockholm, completed a directed share issuances whereby Egetis Therapeutics receives gross proceeds...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Irisity’s Rights Offering

Vinge advised Irisity on the offering. Irisity AB (publ) completed its rights issuance of units consisting of shares and warrants. The issue is guaranteed to 80...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Axcel’s Launch of Accru Partners

Vinge advised Axcel on the deal. Nordic private equity firm Axcel established Accru Partners, a new group of 22 independent firms in Sweden within accounting, tax,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Pandox’s Shares Offering

Vinge advised Pandox on the deal. Pandox Aktiebolag (publ) completed a directed share issuance through which the company raises proceeds of approximately SEK 2 billion before...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here